Adam Perlman
Adam Perlman, a nationally recognized first-chair patent trial lawyer and a Fellow of the American College of Trial Lawyers, represents brand-name pharmaceutical manufacturers and leading life sciences companies in intellectual property litigation. Adam leverages more than 25 years of experience and a solutions-oriented approach to guide clients through every stage of major IP litigation, particularly Hatch-Waxman trials and Federal Circuit appeals. He advocates across a broad range of technologies and sectors, including: Pharmaceuticals Biotechnology and biologics Medical devices As lead counsel in major patent litigation in US district courts and before the US Court of Appeals for the Federal Circuit, he distills complex concepts into compelling advocacy before judges and juries across the country. Adam also routinely litigates life sciences inter partes review proceedings before the US Patent and Trademark Office (USPTO). Adam has argued 11 times before the Federal Circuit since 2012, including before the en banc court in Alice Corp. v. CLS Bank International. A recognized thought leader, Adam frequently speaks on patent litigation issues, including before the Association of Corporate Patent Counsel, the American Conference Institute Paragraph IV Disputes Master Symposium, the American Law Institute course “Trial of a Patent Case,” and other industry groups. Adam has served on the firm’s Associates Committee and Training and Career Enhancement (TACE) Committee. · Latham & Watkins
About
Adam Perlman is a nationally recognized first-chair patent trial lawyer and a Fellow of the American College of Trial Lawyers, representing brand-name pharmaceutical manufacturers and leading life sciences companies in intellectual property litigation. He has over 25 years of experience guiding clients through major IP litigation, including Hatch-Waxman trials and Federal Circuit appeals.